Journal•ISSN: 2352-3026
The Lancet Haematology
Elsevier BV
About: The Lancet Haematology is an academic journal published by Elsevier BV. The journal publishes majorly in the area(s): Medicine & Internal medicine. It has an ISSN identifier of 2352-3026. Over the lifetime, 1183 publications have been published receiving 33097 citations.
Papers
More filters
1,152 citations
TL;DR: The findings show that endotheliopathy is present in COVID-19 and is likely to be associated with critical illness and death, and strategies to mitigate its progression might improve outcomes in CO VID-19.
779 citations
University of Insubria1, University of Pavia2, University of Eastern Piedmont3, University of Bologna4, University of Verona5, Humanitas University6, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico7, University of Milan8, University of Genoa9, University of Catania10, University of Parma11, University of Pisa12, University of Turin13, University of Perugia14, Sapienza University of Rome15, University of Padua16, University of Brescia17, University of Modena and Reggio Emilia18, University of Siena19, University of Udine20, Università Campus Bio-Medico21, Catholic University of the Sacred Heart22
TL;DR: This study adds to the evidence that patients with haematological malignancies have worse outcomes and the general Italian population with COVID-19 has high mortality, by calculating standardised mortality ratios between observed death in the study cohort and expected death by applying stratum-specific mortality rates.
408 citations
University College Hospital1, Aarhus University Hospital2, Vita-Salute San Raffaele University3, Mario Negri Institute for Pharmacological Research4, University of Nottingham5, University of Verona6, The Queen's Medical Center7, University of Göttingen8, Southampton General Hospital9, University of Mainz10, RWTH Aachen University11, University of Ulm12, Technische Universität München13, Martin Luther University of Halle-Wittenberg14
TL;DR: The IELSG32 trial provides a high level of evidence supporting the use of MATRix combination as the new standard chemoimmunotherapy for patients aged up to 70 years with newly diagnosed primary CNS lymphoma and as the control group for future randomised trials.
391 citations
TL;DR: Wang et al. as mentioned in this paper explored the haematological characteristics and related risk factors in patients with COVID-19 and found that the onset of sepsis-induced coagulopathy was typically before overt disseminated intravascular coagulation.
344 citations